Christopher Nathan Martin - 19 Nov 2025 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
Director
Signature
/s/ John R. Moore, Attorney-in-Fact for Christopher Nathan Martin
Issuer symbol
EWTX
Transactions as of
19 Nov 2025
Net transactions value
$0
Form type
4
Filing time
24 Nov 2025, 19:08:49 UTC
Next filing
11 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Martin Christopher Nathan Director 1715 38TH STREET, BOULDER /s/ John R. Moore, Attorney-in-Fact for Christopher Nathan Martin 24 Nov 2025 0002097992

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Stock Options (Right to buy) Award $0 +45,150 $0.000000 45,150 19 Nov 2025 Common Stock 45,150 $22.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/36th of the shares subject to the option vest each month beginning on December 19, 2025, subject to the Reporting Person continuing as a service provider through each vest date.